Bile acid synthesis impedes tumor-specific T cell responses during liver cancer

Varanasi, Siva Karthik, Chen, Dan, Liu, Yingluo, Johnson, Melissa A., Miller, Cayla M., Ganguly, Souradipta, Lande, Kathryn, LaPorta, Michael A. +25 more·2025·Science

Cited by (174)

Items 101–174 of 174

  1. Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.
    Qing Li, Rodrigo de Oliveira Formiga, H. Sokol · 2026 · Trends in immunology
  2. GOLM1 and bile acid synthesis: Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
    2025
  3. Radiopaque microsphere-hydrogel composite for extended-release intratumoral immunotherapy in a large animal model
    2026
  4. Decoding the microbiome-immune crosstalk in cancer: from mechanisms to therapeutic translation
    Ning Zhao, Liang Wu, Sha Peng, Hui Yang, 宋永春, Yong Zhang, Lingwen Ding · 2026 · Biomarker Research
  5. Regulation of immune tolerance in hepatocellular carcinoma by liver diseases: a review
    Jinyi Li, Yuanda Liu · 2026 · Infectious Agents and Cancer
  6. MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort study
    Hong Wei, Subin Heo, Yang Yang, Mengsi Li, Fangfang Fu, Tianyi Xia, Seung Soo Lee, Eun Sun Choi, Riccardo Sartoris, Jules Grégory et al. · 2026 · Journal of Hepatology
  7. EID1 blockade potentiates immunosurveillance against cancer metastasis via FPR1-mediated DC-NK crosstalk
    Ziqi Jin, Xiao Zhang, Huijuan Zhang, Siying Qin, Siqi Zhang, Shuqing Zhang, Lin Xia, Peipei Li, Wen Xu, Peng Liu et al. · 2026 · Science China Life Sciences
  8. Spatial dynamics of the tumor microenvironment linked to emerging resistance in EGFR -mutated lung cancer
    Satoshi Nakamura, Daisuke Shibahara, Kentaro Tanaka, Yasuyuki Kishikawa, Mikiko Hashisako, Keita Nakatomi, Noriaki Nakagaki, Mikihiro Kohno, Koichi Azuma, Ritsu Ibusuki et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Immune cytokines as a bridge linking the gut–liver–ovary axis in the pathogenesis of premature ovarian failure
    Huimin Xu, Muxi Li, Shouyan Yang, Deyou Jiang · 2026 · Frontiers in Endocrinology
  10. Toward Microbiome-Informed Melanoma Care: The Gut Microbiota in Melanoma Evolution, Immunotherapy Response and Immune-Related Toxicity
    Dimitrios C. Ziogas, Charalampos Theocharopoulos, Anastasios Martinos, Georgios Lyrarakis, Dimitra T. Stefanou, Amalia N. Anastasopoulou, Helen Gogas · 2026 · Current Oncology Reports
  11. Integrative Profiling of Metabolic CYP Expression, DNA Mutation Rates, and Immune Cell Infiltration for Survival Prognosis in Hepatocellular Carcinoma
    Mona Dawood, Axel Guthart, Edna Ooko, Ralf Weiskirchen, Thomas Efferth, Joelle C. Boulos · 2026 · Livers
  12. Gut microbial metabolites for potentiating cancer therapy
    Stephan Kamrad, Nicola Gagliani, Trevor D. Lawley, Kiran Raosaheb Patil, Joseph Tintelnot · 2026 · Trends in cancer
  13. Bile acid species as hepatic T lymphocyte response modulators – when bile acids interfere with tumor growth
    David C. Trampert · 2025 · Journal of Hepatology
  14. Single-cell RNA sequencing and spatial transcriptomic analysis reveal a distinct population of G6PD+ cells with aberrant bile acid metabolism in hepatocellular carcinoma
    Xing Jiang, Haiyan Quan, Ting Yin, Hailun Yao, Yajun Li, Bin Peng, Xinye Yuan, Weiguang Zeng, Honghui Chen, Rong Li · 2026 · Frontiers in Immunology
  15. Harnessing the gut microbiota to enhance immune checkpoint inhibitor efficacy: from mechanistic insights to clinical translation
    Qinsheng Bi, L Zhang, Hejia Wan, Jiaxin Zhang · 2026 · Molecular Biology Reports
  16. Resveratrol Alleviates Arsenic-Induced Liver Fibrosis in Rats by Correcting SIRT1-Mediated Disorder of Hepatic Bile Acid Metabolism
    Qi Wang, Hualin Chen, Qiming Ran, Fang Hu, Qiwen Fu, Lu Ma · 2026 · International Journal of Molecular Sciences
  17. Bile Acids and Healthy Ageing
    Brecht J. Attema, Folkert Kuipers · 2026 · Engineering
  18. Molecular insights into early malignant transition of hepatocellular carcinoma
    Zhengtao Zhang, Hong Li, Ling-Li Chen, Tao Lu, Xinyi Shentu, Yuan-Hua Liu, S. Ji, Zhixin Qiu, Yi-Ning Zou, Hong-Lin Wen et al. · 2025 · bioRxiv
  19. A translational model of MASLD-associated HFpEF defines mitochondrial dysfunction and cardiac plasticity during disease progression and regression
    Souradipta Ganguly, Betul Beyza Gunes, Yusu Gu, Jorge Suárez, Gautam Gupta, Kei Ishizuka, Rabi Murad, Tatiana Kisseleva, Wolfgang H. Dillmann, Kirk L. Peterson et al. · 2026 · Metabolism
  20. Advances in bile acid metabolism-mediated immunomodulation
    Lu BAI, Fang Yang, Leng HAN, Cheng GUO, Quan-Jun YANG · 2026 · Shengming kexue
  21. Bile acid metabolism and invasion-related genes as therapeutic monitoring biomarkers in non-small cell lung cancer
    Guangteng Wu, Lin Zhu, Feng Xue, Yanyi Zhao · 2025 · Discover Oncology
  22. Screening of known gut microbiome-derived metabolites in anti-tumor immunity of colorectal cancer
    Xinan Zhang, Zixuan Li, Hui Hua, Hao Song, Sangni Qian, Xin Huang, Guiqin Ye, Yingyu Huang, Qin Wang, Boan Zheng et al. · 2026 · Journal for ImmunoTherapy of Cancer
  23. Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation
    Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai, Takuma Irie, Takumi Habu, Shota Fukuoka, Atsushi Kumanogoh, Naoya Sakamoto, Genichiro Ishii et al. · 2026 · Cancer Immunology Research
  24. Dysregulated Lipid Metabolism in Hepatocellular Carcinoma: Mechanisms and Therapeutic Strategies
    Yi Yi, Xi Liu, Xi Zhang, Yongsheng Li, Huakan Zhao · 2026 · MedComm – Oncology
  25. Deoxycholic acid impairs mitochondrial fitness and suppresses mitophagy through Parkin ubiquitination driving CD8+ T cell Exhaustion in Colorectal Cancer
    Gao Y, Jiaxin Wang, Shihui Lai, Mingwei Li, Shi Jl, Xianjun Li, Ying Guo, Sainan Ma, Xinxin Wang, Shule Zhang et al. · 2026 · Redox Biology
  26. Click chemistry approach to bioactive conjugates of bile acids and sterols
    Anna Kawka, Hanna Koenig, Tomasz Pospieszny · 2026 · Studies in natural products chemistry
  27. Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions
    Chuying Yu, Xintong Ye, Haoyu Zhao, 钱素婷, Feifei Xie, Qingsheng Liu · 2026 · Frontiers in Endocrinology
  28. A new incompatible combination: Reynoutria multiflora combined with Cullen corylifolium enhances idiosyncratic hepatotoxicity under immunological stress
    2025
  29. Discovery and Validation of COL11A1 as a Therapeutic Target for Sorafenib Resistance in Lung Adenocarcinoma
    2026
  30. The interplay between lipid metabolism, cancer progression and anti-cancer immunity
    Choong‐Hyun Koh, Yoosun Lee, Il‐Kyu Kim, Yeonseok Chung · 2026 · Experimental & Molecular Medicine
  31. The conjugation-resistant bile acid norUDCA cures liver fibrosis but impairs systemic energy metabolism
    Jöerg Heeren, Ioannis Evangelakos, Esther Verkade, Folkert Kuipers, Julia Sarah Rohde, Markus Heine, Anna Worthmann, Sebastian Graute, Manka M. Fuh, Karthikeyan Gunasekaran et al. · 2025 · Research Square
  32. Chenodeoxycholic acid restrains tumor growth via TGR5-dependent type 1 dendritic cells cross-priming
    Fanlian Zeng, Fulei Zhao, Pei Zhou, Ya Li, Xiaoyan Wang, Yawen Hu, Jiadong Yu, Guolin Li, Chengcheng Yue, Yuting Feng et al. · 2026 · Signal Transduction and Targeted Therapy
  33. Antibiotic-induced gut microbiota dysbiosis and bile acid metabolism: implications for intestinal health, immune regulation, and disease susceptibility
    Tareq Nayef AlRamadneh, Jasur Rizaev, Malathi Hanumanthayya, Maryam Abdul Al-Hussein, Ahmed Faisal Mutee, Mukhammadali Buriev, Nasiba Jumaniyazova, Shefali · 2026 · Frontiers in Microbiology
  34. On the use of UDCA beyond cholestatic liver disease: How bile acid-driven intestinal GLP-1 signalling keeps the joints healthy
    David C. Trampert · 2026 · Journal of Hepatology
  35. Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes
    Mario Romeo, Claudio Basile, Giuseppina Martinelli, Fiammetta Di Nardo, Carmine Napolitano, Alessia De Gregorio, Paolo Vaia, Luigi Di Puorto, Mattia Indipendente, Alessandro Federico et al. · 2026 · Cancers
  36. Chemical dissection of sterol and bile acid signaling via clickable photoaffinity probes
    Miaomiao Xu, Xiaoming Chen, Jian Ma, Xinglin Yang · 2025 · Biophysics Reports
  37. Mechanisms and Clinical Significance of Bile Acid Metabolism Reprogramming in Hepatocellular Carcinoma Immunotherapy Response
    Tianmin Zhou, Ruixin Wang, Hao Wei, Wenli Liu, Yingqun Xiao, Qingmei Zhong, Zhuoqi Liu, Daya Luo, Kunpeng Jiang, Ping Zhang et al. · 2026 · Research Square
  38. Microbial Signals in Cancer: Dissecting Host–Microbiota–Tumor Interactions and Potential Therapeutic Strategy
    Juan Lu, Mengjuan Xuan, Liang Yu, Zhongyang Xie, Qingfei Chu, Shihui Wei, Tao Wang, Chen Xue, Lanjuan Li · 2026 · MedComm
  39. Functionalized nanopipettes for pH-gated single cell DNA delivery
    2025
  40. TBA-MLR score: a metabolic-immune prognostic biomarker for postoperative hepatocellular carcinoma
    Yuanquan Zhao, Wei Huang, Xiwen Deng, Pengyang Li, Siyang Yao, Yongyu Yang, Xiaofeng Dong · 2025 · Frontiers in Immunology
  41. Hepatocellular carcinoma tumor immune microenvironment: heterogeneity and therapeutic strategies
    Taishun Mao, Junqing Jiang, Ping Liu, Yongxiang Zhao, Liping Zhong, Zerui Zhang, Kaichun Wu, Limin Xia · 2026 · Hepatoma Research
  42. Lithocholic acid-activated VDR in macrophages promotes HCC recurrence post-ablation via SOCS3-mediated suppression of CXCL16
    Rumei Li, Wanrong Luo, Zhaoxi Li, Sui Zheng, Man Luo, Qiuxia Wei, Xiaotong Zhu, Wenyue Zhang, Baoming Luo · 2026 · Journal for ImmunoTherapy of Cancer
  43. Comparative analysis of lipid-lowering mechanisms in efficacy-divergent traditional Chinese medicines
    2026
  44. Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma
    亚峰 刘 · 2026 · Pharmacy Information
  45. Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinoma
    Qianhui Xu, Hang Chen, Ganggang Wang, Xiaodong Wang, JieYi Shi, Yifei Cheng, Yanan Xu, Sainan Ma, Siqi Guo, Xiyang Liu et al. · 2026 · Cancer Letters
  46. Decoding the Biological Function of Bile Acids for Drug Discovery
    Jun Yang, Xiaoguang Lei · 2026 · Accounts of Chemical Research
  47. Inhibition of bile acid conjugation improves cholestatic liver injury in mice with a humanized bile acid pool
    Claudia Daniela Fuchs, Oleksandr Petrenko, Veronika Mlitz, Emmanuel Dauda Dixon, Hubert Scharnagl, Ahmed Ghallab, Thomas Reiberger, Benjamin P. Garfinkel, Michael A Trauner · 2026 · npj gut and liver.
  48. Iron exacerbates congenital cholestatic liver injury via bile acid-induced ferroptosis
    Toshiro Moroishi, Yudai Ohta, Yohei Kanamori, Ayato Maeda, Mohammad Saleh, Akihiro Nita, Takashi Matsumoto, Keiichi I. Nakayama · 2025 · Research Square
  49. Gut microbiota-metabolism-immunity axis: a novel perspective of traditional Chinese medicine in hepatocellular carcinoma treatment
    Xuemei Zhang, Liming Zheng, Jia Shi, Shihan Yu, Wenlan Zheng, Hao Liu, Zhengzheng Wu, Hai Feng, Yueqiu Gao, Zhuo Yu · 2026 · Chinese Medicine
  50. Preoperative albumin-bilirubin grade combined with sarcopenia predicts long-term outcomes after laparoscopic gastrectomy for advanced gastric cancer
    2025
  51. A Translational Model of MASLD-Associated HFpEF Defines Mitochondrial Dysfunction and Cardiac Plasticity During Disease Progression and Regression
    Souradipta Ganguly, Betul Beyza Gunes, Yusu Gu et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  52. The gut microbiome–tumor microenvironment axis in immunotherapy response: Mechanistic insights and clinical implications
    Atul Kumar Gupta · 2026 · International Journal of Molecular and Immuno Oncology
  53. Signaling Pathway Remodeling and Molecular Regulation in the HCC TME: Dynamic Evolution and Clinical Therapeutic Advances
    Lin Xu, Xuanhao Zhang, Hengzhou Zhu, Dong Niu, Xiaodan Zhu, Chunhui Jin · 2026 · Frontiers in Bioscience-Landmark
  54. The conjugation-resistant bile acid norUDCA cures liver fibrosis but impairs systemic energy metabolism
    Ioannis Evangelakos, Esther Verkade, Julia K. Rohde, Alex Zaufel, Martin Vargek, Markus Heine, Anna Worthmann, Sebastian Graute, Marceline Manka Fuh, Karthikeyan Gunasekaran et al. · 2026 · Molecular Metabolism
  55. Extended-Release Immunotherapy-Eluting Embolics
    Imran Shair Mohammad, Anup Kumar Patel, Steven T Rosen, Marcin Kortylewski, Jonathan Kessler, Julie Ressler, Chandana G. Lall, Catalina Guerra, Jason Chiang, Franz Edward Boas · 2026 · Cancers
  56. Crosstalk between CD8+ T cells and systemic bile acid metabolism shapes antiviral immunity and immunopathology
    Felix Clemens Richter, Zsofia Keszei, Csilla Viczenczová, Maximilian Baumgartner, Henrique G. Colaço, Magdalena Siller, Lisa Holnsteiner, Hatoon Baazim, Anna Hofmann, Aubrey Burrett et al. · 2026 · JCI Insight
  57. Polysaccharides-gut microbiota interaction: mechanisms regulating the hepatocellular carcinoma immune microenvironment
    Wei Peng, Kai Xiong, Yuyang Zheng, Jiahan Zheng, Yuanyuan Zhong, Jihao Yang, Yuchuan Jiang · 2026 · Frontiers in Immunology
  58. The Role and Mechanistic Effects of Gut Microbiota Metabolites in Immunotherapy for Hepatocellular Carcinoma
    Yau-Tuen Chan, Pengde Lu, Jiaqi Zou, Zhuofeng Jiang, Lin Xu, Ning Wang · 2026 · Cancer Biome and Targeted Therapy
  59. Ursodeoxycholic acid boosts treatment efficacy for hepatocellular carcinoma patients receiving immunotherapy
    Tongsheng Yang, 郑林星, Hong Mei Wu, Tian Lan · 2025 · International Journal of Surgery
  60. Age differentially impacts the efficacy of booster vaccination against severe COVID-19 caused by Omicron: Enhanced vulnerability to immune imprinting in the elderly mediated by immunosenescence
    Ke Qiu, Qian Zhu, Dachuan Cai, Zhiling Deng, Guanhua Zha, Yunling Xue, Mingli Peng, P Hu, Hong Ren · 2026 · Genes & Diseases
  61. Dysbiosis-associated bile acids slam the brakes on immune checkpoint therapy
    Chi Chun Wong, Jun Qing Yu · 2026 · Cancer Cell
  62. Causal Associations of Cerebrospinal Fluid and Circulating Metabolites With Malignant Brain Neoplasms: A Mendelian Randomization Analysis
    Xinyin Zhang, Zhicheng Wu, Jing Tan · 2026 · Brain and Behavior
  63. Zonated cholesterol sensing by SIRT2 drives MASLD-HCC
    Yingting Zhang, 龙喜带, Yinkun Fu, Xinxin Tang, Hao Luo, Zhihui Zou, Wei He, Longchuan Han, Yue Li, Jing Luo et al. · 2026 · Cell Metabolism
  64. Acute myocardial infarction induces sex-specific, time-dependent remodeling of the gut microbiome and intestinal immune compartment in retired breeder C57BL/6N mice
    Eszter Pal, Neda Omidi Arjenaki, Yao Lu, Jianguo Xia, Lorraine E. Chalifour · 2026 · Frontiers in Microbiomes
  65. Bile acids in cancer: From metabolism to immunomodulation
    Qian Fang, Kai Markus Schneider · 2026 · Immunity
  66. CD47-SIRPα axis mediated by ncRNA correlates with poor prognosis, immune microenvironment dysregulation and lipid metabolism modulation in hepatocellular carcinoma
    Huijie Gao, Cuimin Hu, Qing Wu, Zhong-Ze Fang · 2026 · International Journal of Biological Macromolecules
  67. Lithocholic acid alleviates fatty liver in mice and non-human primate macaques
    Qi Qu, Yan Chen, Guo Shen, Xiaojiao Huang, Fang-Han Li, Xiaojun Wang, Cixiong Zhang, Zhumei Wei, Liping Xie, Jianfeng Wu et al. · 2026 · Life Metabolism
  68. Effect of Butyrate‐Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and Tremelimumab
    Kazuhiro Nouso, Akiko Wakuta, Shohei Shiota, Rio Fujita, Kazuya Kariyama, Atsushi Hiraoka, Masanori Atsukawa, Joji Tani, Toshifumi Tada, Shinichiro Nakamura et al. · 2026 · JGH Open
  69. Metabolic interactions of host-gut microbiota: Shaping the future of precision diagnosis and therapeutic discovery in gastrointestinal cancers
    Jiaxin Zhang, Jingjing Liu, Yuan Tian, Wei Jia, Ge Zhang, Aiping Lü, Haitao Lyu · 2026 · Pharmacological Research
  70. Anti-Cancer Effects of Quercetin: What Role Does the Gut Microbiota Play?
    Guang Yi, Ying Liu, Guangye Li, Ke Chang · 2026 · Molecules
  71. Single-cell transcriptomics reveals a novel mechanism of RDH16 regulating immune infiltration in hepatocellular carcinoma
    2026
  72. Psychological Stress Associated Bile Acid Reprogramming Promotes Hepatocellular Carcinoma Progression
    Ruijiang Zeng, Mengmeng Wang, Kang Wang et al. · 2026 · Advanced Science
  73. Letter to the Editor: Bile acids in cholangiocarcinoma: Dual regulation via the hippo-yes-associated protein pathway and model limitations
    2026
  74. Taurine Facilitates the Formation of Hepatocellular Carcinoma via the Bile Acid Pathway
    2025